Although evidence of increased autophagy in the presence of other Akt inhibitors in GBM cells already exists, the role of induced autophagy in GBM is highly controversial with data corroborating both protective and detrimental effects of therapy-induced autophagy [11,13,67,68,69]. This evidence concerns the gene AKT1 and glioblastoma.